middle.news
How Will ReNerve’s $3.2M Raise Transform Its US Nerve Repair Push?
9:55am on Thursday 20th of November, 2025 AEDT
•
Healthcare
Read Story
How Will ReNerve’s $3.2M Raise Transform Its US Nerve Repair Push?
9:55am on Thursday 20th of November, 2025 AEDT
Key Points
Completed $3.2M capital raising via 26.7 million shares at $0.12 each
Placement includes unconditional and conditional tranches, with shareholder approval pending for the latter
Funds earmarked to accelerate US sales, marketing, and new product development
Attaching options offered subject to shareholder approval at January 2026 EGM
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Renerve (ASX:RNV)
OPEN ARTICLE